White blood cell treatment could prevent leading cause of fetal death

December 12, 2016, Queen Mary, University of London
pregnancy

Treating a type of white blood cell using hormones could improve the development of the placenta in women with pregnancy complications, according to early research led by Queen Mary University of London (QMUL) involving mice and human blood samples.

Pre-eclampsia is a condition in some that results in poor maternal vessel development in the placenta, leading to poor foetal growth. According to the World Health Organization, it is one of the leading causes of maternal and foetal morbidity and mortality in both the developed and developing world, occurring in 2-8 per cent of all pregnancies.

The study, funded by the Wellcome Trust and British Heart Foundation and published in Proceedings of the National Academy of Sciences, looked specifically at neutrophils - short-lived that act as the first line of defence in infections - and discovered a new role for them in maintaining a healthy pregnancy.

The researchers studied and compared the blood from healthy and pre-eclamptic pregnant women. In the healthy women's blood, they saw that neutrophils interacted with T-cells - another type of white blood cell essential for the immune system. In contrast with the healthy pregnancies, the neutrophils failed to interact with the T-cells in the blood from pre-eclamptic women.

The authors suggest that there are signs that, in healthy pregnancies, neutrophils play a role in helping the T-cells to promote blood vessel growth and give rise to normal placental development, suggesting that this could be a potential therapeutic target for .

In tests outside of the human body, the team treated the neutrophils from pre-eclamptic women with pregnancy hormones progesterone and estriol, and found that they were able to begin normal interactions with their T-cells.

Further tests in pregnant mice with pre-eclampsia found that if neutrophils underwent the same hormone treatment, and were re-infused into the mouse, placental development began to return to normal.

Study author Dr Suchita Nadkarni from QMUL said: "Although we're a long way off and need to confirm these results in a much larger cohort of patients, this could eventually form part of therapy for pregnancy complications. If we could replicate in humans what we've done in mice, and re-introduce the treated neutrophils back into their blood, we may see normal placental development in pregnant women diagnosed with pre-eclampsia.

"In the meantime, however, these results give us a much better insight into how the maternal immune system works during pregnancy, and why in some cases it might not work and lead to complications."

Explore further: Maternal blood test may predict birth complications

More information: Neutrophils induce proangiogenic T cells with a regulatory phenotype in pregnancy, PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1611944114

Related Stories

Maternal blood test may predict birth complications

October 24, 2016
A protein found in the blood of pregnant women could be used to develop tests to determine the health of their babies and aid decisions on early elective deliveries, according to an early study led by Queen Mary University ...

Kidney disease risk for some pregnant women

November 17, 2016
Research from the University of Aberdeen has found that that there was an increased risk of chronic kidney disease later in life for mothers who had high blood pressure during pregnancy.

Study links small RNA molecule to pregnancy complication

October 24, 2016
A family of small RNA molecules affects the development of cells that give rise to the placenta - an organ that transfers oxygen and nutrients from mother to fetus—in ways that could contribute to a serious pregnancy complication, ...

Pre-pregnancy heart abnormalities may predict recurrent preeclampsia risk

February 22, 2016
Women who had pregnancy-related high blood pressure multiple times had recognizable heart abnormalities between pregnancies that could help predict their risk for heart and blood vessel disease during subsequent pregnancies ...

Genetics point to serious pregnancy complication

November 15, 2012
New research at the University of Adelaide has revealed a genetic link in pregnant mums - and their male partners - to pre-eclampsia, a life-threatening complication during pregnancy.

Researcher investigating whether self-monitoring of blood pressure can result in earlier pre-eclampsia diagnosis

July 12, 2016
An academic from City University London is working with colleagues from across the UK to explore whether giving pregnant women the means to monitor their own blood pressure and urine safely from home can result in an earlier ...

Recommended for you

Unexpected immune activation illustrated in the cold

February 19, 2018
Researchers at Utrecht University and Leiden University Medical Center, the Netherlands, have imaged an important immune system on-switch. Their novel technical approach has led to the discovery of two ways in which the immune ...

Immune signature predicts asthma susceptibility

February 16, 2018
Asthma is a chronic inflammatory disease driven by the interplay of genetics, environmental factors and a diverse cast of immune cells. In their latest study, researchers at La Jolla Institute for Allergy and Immunology (LJI) ...

Scientists identify immune cascade that fuels complications, tissue damage in chlamydia infections

February 13, 2018
Closing a critical gap in knowledge, Harvard Medical School scientists have unraveled the immune cascade that fuels tissue damage and disease development in chlamydia infection—the most common sexually transmitted disease ...

Mouse study adds to evidence linking gut bacteria and obesity

February 12, 2018
A new Johns Hopkins study of mice with the rodent equivalent of metabolic syndrome has added to evidence that the intestinal microbiome—a "garden" of bacterial, viral and fungal genes—plays a substantial role in the development ...

Cancer killing clue could lead to safer and more powerful immunotherapies

February 12, 2018
New research could help to safely adapt a new immunotherapy—currently only effective in blood cancers—for the treatment of solid cancers, such as notoriously hard-to-treat brain tumours.

Mechanism behind autoimmune disorder revealed

February 7, 2018
Northwestern Medicine scientists discovered a previously-unknown mechanism of disease behind a specific autoimmune disorder, findings published in the Proceedings of the National Academy of Sciences.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.